A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma

A novel sphingolipid metabolism-related long noncoding RNA signature predicts the prognosis, immune landscape and therapeutic response in pancreatic adenocarcinoma

Sphingolipid metabolism affects prognosis and resistance to immunotherapy in patients with cancer and is an emerging target in cancer therapy with promising diagnostic and prognostic value. Long noncoding ribonucleic acids (lncRNAs) broadly regulate tumour-associated metabolic reprogramming. However...

Full description

Bibliographic Details
Main Authors:	Xiaolan He, Zhengyang Xu, Ruiping Ren, Peng Wan, Yu Zhang, Liangliang Wang, Ying Han
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Heliyon
Subjects:	Sphingolipid metabolism Pancreatic adenocarcinoma lncRNA Prognosis Tumor immune microenvironment Tumor biomarker
Online Access:	http://www.sciencedirect.com/science/article/pii/S240584402310867X

Similar Items

Disulfidptosis-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in colon adenocarcinoma
by: Weijie Xue, et al.
Published: (2023-09-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01)

A disulfidptosis-related lncRNA signature for predicting prognosis and evaluating the tumor immune microenvironment of lung adenocarcinoma
by: Zipei Song, et al.
Published: (2024-02-01)

A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma
by: Kai Zhao, et al.
Published: (2022-07-01)

M6A-Related Long Non-Coding RNA Displays Utility in Predicting Prognosis, Portraying the Tumor Immune Microenvironment and Guiding Immunotherapy in Pancreatic Ductal Adenocarcinoma
by: Guangyu Xu, et al.
Published: (2023-02-01)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
by: Chao Ma, et al.
Published: (2023-08-01)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
by: Hui Chen, et al.
Published: (2023-01-01)

A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma
by: Xueying Fang, et al.
Published: (2022-11-01)

Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment
by: Yuanyong Wang, et al.
Published: (2022-08-01)

Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma
by: Yingquan Ye, et al.
Published: (2022-09-01)

Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma
by: Lincheng Li, et al.
Published: (2022-11-01)

By integrating single-cell RNA-seq and bulk RNA-seq in sphingolipid metabolism, CACYBP was identified as a potential therapeutic target in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01)

The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma
by: Cong Liu, et al.
Published: (2022-06-01)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
by: Weijia Wang, et al.
Published: (2021-02-01)

Development and validation of a ferroptosis-related lncRNAs signature to predict prognosis and microenvironment for melanoma
by: Shuai Ping, et al.
Published: (2022-11-01)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
by: Chenhao Zhou, et al.
Published: (2019-11-01)

Long noncoding RNA: a dazzling dancer in tumor immune microenvironment
by: Yalu Zhang, et al.
Published: (2020-11-01)

Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma
by: Yuxin Wang, et al.
Published: (2022-09-01)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
by: Jie Zhang, et al.
Published: (2019-04-01)

Metabolism‐related lncRNAs signature to predict the prognosis of colon adenocarcinoma
by: Yimin Sun, et al.
Published: (2023-03-01)

Neural Component of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma
by: Michał Gola, et al.
Published: (2022-10-01)

Identification of a prognostic classifier based on EMT-related lncRNAs and the function of LINC01138 in tumor progression for lung adenocarcinoma
by: Lingyan Xiao, et al.
Published: (2022-08-01)

Necroptosis-related lncRNA in lung adenocarcinoma: A comprehensive analysis based on a prognosis model and a competing endogenous RNA network
by: Fuling Mao, et al.
Published: (2022-09-01)

The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers
by: Sheng-Kai Hsu, et al.
Published: (2023-03-01)

Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients
by: Zi-Rong Jiang, et al.
Published: (2022-09-01)

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
by: Jia-Hao Zheng, et al.
Published: (2022-10-01)

An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma
by: Xiaobo Wang, et al.
Published: (2024-02-01)

The coagulation-related genes for prognosis and tumor microenvironment in pancreatic ductal adenocarcinoma
by: Di Wang, et al.
Published: (2023-06-01)

Multi-level integrative analysis of the roles of lncRNAs and differential mRNAs in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma
by: Zhirong Zhao, et al.
Published: (2023-03-01)

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
by: Ashleigh R. Poh, et al.
Published: (2021-06-01)

A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs
by: Yang Liu, et al.
Published: (2022-09-01)

Identification of m7G-Related LncRNA Signature for Predicting Prognosis and Evaluating Tumor Immune Infiltration in Pancreatic Adenocarcinoma
by: Jiawei Lu, et al.
Published: (2023-05-01)

An Angiogenesis-Related lncRNA Signature Is Associated with Prognosis and Tumor Immune Microenvironment in Breast Cancer
by: Shun Gao, et al.
Published: (2023-03-01)

Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies
by: Songyu Guo, et al.
Published: (2024-03-01)

AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma
by: Guo Chen, et al.
Published: (2022-05-01)

A novel glycosyltransferase-related lncRNA signature correlates with lung adenocarcinoma prognosis
by: Chengyu Bian, et al.
Published: (2022-08-01)

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
by: Yang Wu, et al.
Published: (2021-01-01)

CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma
by: Huimin Huang, et al.
Published: (2021-02-01)

Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature
by: Yujian Zhong, et al.
Published: (2022-10-01)

Genome-wide Exploration of a Pyroptosis-Related Long Non-Coding RNA Signature Associated With the Prognosis and Immune Response in Patients With Bladder Cancer
by: Xin Gao, et al.
Published: (2022-04-01)